VolitionRX Limited (NYSEAMERICAN:VNRX – Get Free Report)’s share price passed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $0.49 and traded as low as $0.3077. VolitionRX shares last traded at $0.3220, with a volume of 554,005 shares changing hands.
VolitionRX Trading Down 3.5%
The firm has a market capitalization of $34.65 million, a PE ratio of -1.29 and a beta of 1.27. The firm’s fifty day moving average price is $0.49 and its 200 day moving average price is $0.59.
VolitionRX Company Profile
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 in the United States and internationally. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes.
Featured Stories
- Five stocks we like better than VolitionRX
- What is a Low P/E Ratio and What Does it Tell Investors?
- Wall Street Loves Williams-Sonoma Right Now—Here’s Why the Stock Could Soar in 2026
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Meta Wins FTC Fight, Keeps Instagram Growth Machine Intact
- Options Trading – Understanding Strike Price
- Red Cups or Red Flags: Starbucks’ Bet on a Holiday Recovery
Receive News & Ratings for VolitionRX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VolitionRX and related companies with MarketBeat.com's FREE daily email newsletter.
